30 years of historical data (1995–2024) · Healthcare · Biotechnology
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
XOMA Royalty Corp. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $305M | $308M | $212M | $210M | $254M | $508M | $239M | $106M | $284M | $25M | $157M |
| Enterprise Value | $323M | $325M | $183M | $152M | $161M | $445M | $215M | $83M | $255M | $43M | $140M |
| P/E Ratio → | -15.48 | — | — | — | 32.08 | 56.58 | — | — | 48.77 | — | — |
| P/S Ratio | 10.72 | 10.79 | 44.60 | 34.84 | 6.66 | 17.28 | 13.02 | 19.99 | 5.39 | 4.57 | 2.83 |
| P/B Ratio | 3.65 | 3.75 | 2.39 | 1.69 | 1.79 | 5.87 | 5.44 | 5.64 | 49.10 | — | — |
| P/FCF | — | — | — | — | — | 57.15 | — | — | 106.08 | — | — |
| P/OCF | — | — | — | — | 11.21 | 50.30 | — | — | 105.77 | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 11.41 | 38.54 | 25.25 | 4.22 | 15.13 | 11.73 | 15.59 | 4.84 | 7.70 | 2.52 |
| EV / EBITDA | — | — | — | — | 9.10 | 35.32 | — | — | 14.72 | — | — |
| EV / EBIT | — | — | — | — | 9.85 | 32.60 | — | — | 14.59 | — | — |
| EV / FCF | — | — | — | — | — | 50.06 | — | — | 95.29 | — | — |
Margins and return-on-capital ratios measuring operating efficiency
XOMA Royalty Corp. earns an operating margin of -140.3%. Operating margins have expanded from -288.9% to -140.3% over the past 3 years, signaling improving operational efficiency. A negative ROE of -16.2% indicates the company is currently destroying shareholder equity.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 99.3% | 99.3% | 97.0% | 95.5% | 99.6% | 99.4% | 93.2% | 68.3% | 85.1% | 74.8% | 62.7% |
| Operating Margin | -140.3% | -140.3% | -879.5% | -288.9% | 45.9% | 42.3% | -21.1% | -318.1% | 32.3% | -1106.4% | -71.6% |
| Net Profit Margin | -48.5% | -48.5% | -858.2% | -283.8% | 41.4% | 45.3% | -10.8% | -251.8% | 27.7% | -962.1% | -37.2% |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -16.2% | -16.2% | -38.4% | -12.9% | 13.8% | 20.4% | -6.3% | -108.6% | 252.3% | — | -5216.7% |
| ROA | -6.1% | -6.1% | -21.8% | -11.1% | 10.8% | 12.0% | -2.5% | -24.5% | 39.7% | -103.4% | -25.1% |
| ROIC | -37.6% | -37.6% | -49.8% | -22.7% | 36.4% | 42.7% | -37.3% | — | — | — | — |
| ROCE | -19.4% | -19.4% | -24.0% | -12.1% | 13.2% | 12.4% | -5.4% | -35.3% | 101.1% | -257.8% | -75.9% |
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $18M ($119M total debt minus $102M cash).
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.46 | 1.46 | 1.40 | 0.00 | 0.00 | 0.25 | 0.75 | 1.20 | 2.52 | — | — |
| Debt / EBITDA | — | — | — | — | 0.01 | 1.69 | — | — | 0.84 | — | — |
| Net Debt / Equity | — | 0.21 | -0.33 | -0.47 | -0.66 | -0.73 | -0.54 | -1.24 | -4.99 | — | — |
| Net Debt / EBITDA | — | — | — | — | -5.26 | -5.00 | — | — | -1.67 | — | — |
| Debt / FCF | — | — | — | — | — | -7.09 | — | — | -10.79 | — | — |
| Interest Coverage | -2.89 | -2.89 | -73.55 | — | 38.02 | 6.73 | -2.02 | -18.28 | 13.76 | -15.60 | -9.50 |
Short-term solvency ratios and asset-utilisation metrics
XOMA Royalty Corp.'s current ratio of 5.15x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has declined from 8.98x to 5.15x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.15 | 5.15 | 8.68 | 8.98 | 7.48 | 7.16 | 6.76 | 8.35 | 5.95 | 0.84 | 3.10 |
| Quick Ratio | 5.15 | 5.15 | 8.68 | 8.98 | 7.48 | 7.03 | 6.76 | 8.35 | 5.95 | 0.84 | 3.10 |
| Cash Ratio | 4.32 | 4.32 | 7.87 | 8.53 | 7.26 | 6.85 | 6.39 | 8.03 | 5.86 | 0.79 | 2.84 |
| Asset Turnover | — | 0.13 | 0.02 | 0.04 | 0.23 | 0.23 | 0.19 | 0.08 | 1.17 | 0.19 | 0.74 |
| Inventory Turnover | 0.11 | — | — | — | — | 0.11 | — | — | — | — | — |
| Days Sales Outstanding | — | 218.01 | 1167.49 | 143.35 | 2.00 | 22.22 | 58.28 | 101.12 | 2.75 | 37.13 | 26.79 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
XOMA Royalty Corp. returns 1.8% to shareholders annually — split between a 1.8% dividend yield and 0.0% buyback yield.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.8% | 1.8% | 2.6% | 2.6% | 1.4% | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | 3.1% | 1.8% | — | — | 2.1% | — | — |
| FCF Yield | — | — | — | — | — | 1.7% | — | — | 0.9% | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 1.8% | 1.8% | 2.6% | 2.6% | 1.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $12M | $11M | $11M | $12M | $12M | $9M | $8M | $8M | $6M | $6M |
Compare XOMA with 7 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $305M | -15.5 | — | — | 99.3% | -140.3% | -16.2% | -37.6% | — | |
| $7B | 26.6 | 9.9 | 2.8 | — | 65.6% | 7.7% | 6.7% | 5.7 | |
| $4B | -918.6 | 309.3 | 51.3 | 93.4% | -13.5% | -0.5% | -2.3% | 0.6 | |
| $2B | 6.7 | 5.4 | 8.5 | 72.3% | 38.5% | 29.1% | 16.8% | — | |
| $765M | 38.6 | 21.4 | 2.8 | 100.0% | 87.7% | 1.9% | 1.4% | — | |
| $321M | -15.8 | — | — | 99.3% | -140.3% | -16.2% | -37.6% | — | |
| $106M | -0.3 | — | — | 100.0% | -6062.8% | -115.3% | -86.2% | — | |
| $30M | -0.0 | — | — | — | — | — | — | — | |
| Healthcare Median | — | 23.3 | 13.6 | 18.1 | 66.0% | -6.6% | -36.9% | -13.6% | 3.0 |
Peers based on L4 peer group classification. Compare multiple stocks →
Includes 30+ ratios · 30 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how XOMA stacks up against sector leader Royalty Pharma plc.
Start ComparisonXOMA Royalty Corp.'s current P/E ratio is -15.5x. The historical average is 47.7x.
XOMA Royalty Corp.'s return on equity (ROE) is -16.2%. The historical average is -94.8%.
Based on historical data, XOMA Royalty Corp. is trading at a P/E of -15.5x. Compare with industry peers and growth rates for a complete picture.
XOMA Royalty Corp.'s current dividend yield is 1.83%.
XOMA Royalty Corp. has 99.3% gross margin and -140.3% operating margin.